WBA
29
4
FE
53
-2
HPE
38
4
HRB
32
-10
MA
65
-2
SYF
64
6
CL
50
-8
TXN
38
3
KLAC
61
-2
MSI
35
-11
ICE
73
-2
FLR
43
10
FITB
66
7
FSLR
46
2
STI
36
3
NAVI
47
6
AVB
50
-2
NTAP
54
2
SWKS
36
8
K
65
2
WBA
29
4
FE
53
-2
HPE
38
4
HRB
32
-10
MA
65
-2
SYF
64
6
CL
50
-8
TXN
38
3
KLAC
61
-2
MSI
35
-11
ICE
73
-2
FLR
43
10
FITB
66
7
FSLR
46
2
STI
36
3
NAVI
47
6
AVB
50
-2
NTAP
54
2
SWKS
36
8
K
65
2
Financhill
Back

Apellis Pharmaceuticals Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
30

APLS
Apellis Pharmaceuticals

Last Price:
$27.41
Seasonality Move:
11.8%
Sell
14

EYPT
EyePoint Pharmaceuticals

Last Price:
$6.49
Seasonality Move:
10.98%
Sell
30
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $27.40. The Score for APLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $6.50. The Score for EYPT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $27.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $6.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 36.68 Sell
Chaikin Money Flow: -467229 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.19 - 30.17) Sell
Bollinger Bands (100): (27.51 - 32.67) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 39.78 Sell
Chaikin Money Flow: 52994 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.68 - 8.22) Sell
Bollinger Bands (100): (7.21 - 10.27) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.82 Sell
20-day SMA: 29.35 Sell
50-day SMA: 31.36 Sell
200-day SMA: 34.85 Sell
8-day EMA: 28.42 Sell
20-day EMA: 29.26 Sell
50-day EMA: 30.31 Sell
200-day EMA: 35.99 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.58 Sell
20-day SMA: 7.39 Sell
50-day SMA: 7.7 Sell
200-day SMA: 9.28 Sell
8-day EMA: 6.63 Sell
20-day EMA: 7.13 Sell
50-day EMA: 7.78 Sell
200-day EMA: 9.89 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $1.74 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and a decrease next year of $0.28 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):